Moolec Science (MLECW) Enterprise Value (2022 - 2026)
Moolec Science (MLECW) posted Enterprise Value of -$1.2 million for Q1 2026, down 124.18% sequentially from $5.0 million in Q4 2025.
Moolec Science (MLECW) Enterprise Value (2022 - 2026) Analysis & Trends
Moolec Science has reported Enterprise Value for 5 years, with the latest figure at -$1.2 million in Q1 2026.
- Quarterly Enterprise Value changed N/A year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (changed N/A YoY) and the FY2025 annual result came in at -$26.1 million, down 114.42% from the prior year.
- Enterprise Value slipped to -$1.2 million in Q1 2026 per MLECW's latest filing, from $5.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at $185.4 million in Q2 2023 and troughed at -$228.0 million in Q1 2023.
- A 5-year average of -$1.6 million and a median of -$3.6 million in 2024 frame the typical range for Enterprise Value.
- The widest YoY moves for Enterprise Value: up 665.34% in 2023, down 19030.68% in 2023.
- Over 5 years, Enterprise Value stood at -$10.4 million in 2022, then sank by 320.91% to -$43.9 million in 2023, then climbed by 2.98% to -$42.6 million in 2024, then soared by 111.65% to $5.0 million in 2025, then sank by 124.18% to -$1.2 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$1.2 million, $5.0 million, and -$26.1 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | -1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Jun 30, 2025 | -26.12 Mn |
| Dec 31, 2024 | -42.59 Mn |
| Sep 30, 2024 | -3.61 Mn |
| Jun 30, 2024 | 181.13 Mn |
| Mar 31, 2024 | -4.25 Mn |
| Dec 31, 2023 | -43.90 Mn |
| Sep 30, 2023 | -853,857.00 |
| Jun 30, 2023 | 185.41 Mn |
| Mar 31, 2023 | -228.00 Mn |
| Dec 31, 2022 | -10.43 Mn |
| Sep 30, 2022 | -1.09 Mn |
| Jun 30, 2022 | -32.80 Mn |
| Mar 31, 2022 | -1.19 Mn |